Peripheral Artery Disease (PAD) is a progressive circulatory condition characterized by the narrowing or blockage of peripheral arteries, most commonly affecting the lower limbs. It is primarily caused by atherosclerosis, where plaque buildup reduces blood flow to muscles and tissues. Patients often experience symptoms such as leg pain while walking (claudication), numbness, weakness, and in severe cases, non-healing wounds or gangrene. PAD is closely associated with risk factors including smoking, diabetes, hypertension, obesity, and aging, making it a significant global health concern.
The epidemiology of PAD shows a rising burden worldwide, especially in aging populations and regions with increasing prevalence of lifestyle-related disorders. Despite being underdiagnosed, PAD significantly contributes to morbidity due to its association with cardiovascular complications such as heart attack and stroke. Growing awareness and improved diagnostic techniques, including ankle-brachial index (ABI) testing and advanced imaging modalities, are supporting earlier detection and better disease management.
The <a href="https://www.delveinsight.com/report-store/peripheral-artery-disease-pad-market">Peripheral Artery Disease Treatment Market</a> landscape is evolving with a combination of lifestyle modifications, pharmacological therapies, and interventional procedures. First-line management includes smoking cessation, regular exercise, and dietary improvements. Pharmacological treatments involve antiplatelet agents, statins, and medications to improve blood flow and reduce symptoms. In more advanced cases, minimally invasive procedures such as angioplasty and stent placement are commonly used to restore circulation, while surgical bypass may be required for severe arterial blockages.
The market for Peripheral Artery Disease treatment is expanding steadily due to rising disease prevalence, technological advancements in vascular interventions, and increasing healthcare expenditure. The development of drug-coated balloons, bioresorbable stents, and novel antithrombotic therapies is further driving innovation in this space. Additionally, increasing focus on early diagnosis and preventive care is expected to support market growth in the coming years.
Overall, PAD represents a critical area in vascular medicine with growing clinical and commercial importance, highlighting the need for continued innovation in diagnosis, treatment, and patient management strategies.

Peripheral Artery Disease Market

Peripheral Artery Disease Infographic

Peripheral Artery Disease Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape